Clinical Trial Update: Risk Evaluation and Screening to Tailor Prevention and Reduce the Incidence of Endometrial Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating risk evaluation and screening to tailor prevention and reduce the incidence of endometrial cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: University of British Columbia | Conditions: Endometrium Cancer | Phase 4 | Status: COMPLETED